Lee Schacter

2.9k citations
48 papers · 2.4k · 1 hit paper · h-index 23

Impact in

    • Head and Neck Cancer Studies
  • Genetics top 5%
    • Myeloproliferative Neoplasms: Diagnosis and Treatment
    • Hemoglobinopathies and Related Disorders

Papers in

    • Myeloproliferative Neoplasms: Diagnosis and Treatment 3
    • Hemoglobinopathies and Related Disorders 3
    • Cancer therapeutics and mechanisms 10

Lee Schacter

48 papers receiving 2.2k citations

Lee Schacter's Hit Papers

A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck. 1992 · 520 citations
5200+11+22Years since publication100200300400500

Peers

Lee Schacter
Comparison fields: 5 of 100
  • Otorhinolaryngology 429
  • Genetics 254
  • Oncology 542
  • Hematology 116
  • Health Information Management 69
Replace Sunita Saxena with:
Sunita Saxena India
Semir Vranić Qatar
Michael Philip Hagan United States
Liesbeth Peters-Bax Netherlands
Alessandro Ottaiano Italy
Kazuhiro Yanagihara Japan
Christa Flechtenmacher Germany
Jules E. Harris United States
Warren Allen Chow United States
Nozomu Yanaihara Japan
Lee Schacter relative to Sunita Saxena India Sunita Saxena's profile →
Citations per field
00.5×2×4×6.2×
Sunita Saxena · 1×
Citations per year

Countries citing papers authored by Lee Schacter

Since Specialization
Citations

This map shows the geographic impact of Lee Schacter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lee Schacter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lee Schacter more than expected).

Fields of papers citing papers by Lee Schacter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lee Schacter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lee Schacter. The network helps show where Lee Schacter may publish in the future.

Co-authors

The 25 scholars most cited alongside Lee Schacter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lee Schacter Line = papers co-authored together Lee Schacter links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.

#Work
1
A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck.
Hit paper breakdown →
1992520
2 1992442
3 1991222
4 1988143
5
Etoposide phosphate: what, why, where, and how?
199689
6 199888
7 199055
8 198954
9 201050
10 197649
11 198846
12 200943
13 200641
14 197038
15 197238
16 198535
17 198030
18 199228
19 198227
20 199626

About Lee Schacter

Lee Schacter is a scholar working on Genetics, Molecular Biology, Oncology, Health Information Management and Pathology and Forensic Medicine, having authored 48 papers that have together received 2.4k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (10 papers), Lung Cancer Diagnosis and Treatment (3 papers), Lung Cancer Research Studies (3 papers), Electronic Health Records Systems (3 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers), Hemoglobinopathies and Related Disorders (3 papers), Lung Cancer Treatments and Mutations (2 papers) and HIV/AIDS drug development and treatment (2 papers). The work is most often cited by research in Otorhinolaryngology (429 citations), Genetics (254 citations), Oncology (542 citations), Hematology (116 citations) and Health Information Management (69 citations). Lee Schacter has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Lawrence H. Einhorn, Charlotte Jacobs, Howard S. Höchster, Gary H. Lyman, E Vélez-García, Kasi S. Sridhar, Joanne E. Mortimer, Lawrence T. Goodnough, Harvey Jay Cohen and David H. Johnson. Their work appears in journals such as Journal of Clinical Oncology, Blood, Biochemical and Biophysical Research Communications, JAMA and Cancer Chemotherapy and Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact